Further studies are needed to examine the specific roles of CD8 TEM cells, CCL7, and other candidate features, to identify new diagnostic and therapeutic avenues for patients with long-term cardiac sequelae of COVID-19. The gene discussed is CD8A; the disease is COVID-19.